فهرست و منابع پایان نامه بررسی سطح سرمی پروکلسی تونین در بیماران مبتلا به سل فعال ریوی و مقایسه آن با گروه کنترل
فهرست:
فصل اول: کلیات... 1
1-1- مقدمه و بیان مسئله. 2
2-1 تعریف واژه‌های کلیدی.. 3
3-1 اهداف و فرضیات... 4
1-3-1 هدف کلّی.. 4
2-3-1 اهداف اختصاصی.. 4
3-3-1 هدف کاربردی.. 5
4-3-1 فرضیات یا سؤالات تحقیق.. 5
فصل دوم: پیشینه تحقیق.. 7
1-2 مبانی نظری.. 8
1-1-2 بیماری سل.. 8
2-1-2 اپیدمیولوژی.. 9
3-1-2 اتیولوژی.. 11
4-1-2 مورفولوژی و مشخصات مایکوباکتریوم توبرکلوزیس.... 12
5-1-2 آسیب شناسی.. 13
6-1-2 تظاهرات بالینی.. 15
7-1-2 تشخیص سل.. 31
8-1-2 درمان سل.. 37
9-1-2 پایش پاسخ به درمان. 39
10-1-2 سل مقاوم به درمان. 39
11-1-2 پیشگیری.. 40
2-2 مطالعات مشابه. 41
1-2-2 مطالعات داخلی.. 41
2-2-2 مطالعات خارجی.. 42
فصل سوم: مواد و روش ها 44
1-3 نوع مطالعه. 45
2-3 محیط پژوهش.... 45
3-3 جامعه آماری و حجم نمونه. 45
4-3 روش گردآوری اطلاعات... 45
5-3 روش تجزیه و تحلیل داده ها و بررسی آماری.. 46
6-3 معیار ورود. 46
7-3 معیار خروج.. 46
8-3 ملاحظات اخلاقی.. 46
9-3 محدودیت مطالعه. 47
10-3 متغیر های مطالعه. 48
11-3 روش آزمایشگاهی 49
فصل چهارم: نتایج.. 52
فصل پنجم: بحث و نتیجه گیری.. 73
پیشنهادات... 80
منابع .
منبع:
World Healt Organization: Global Tuberculosis control surveillance, planning and Financing. WHO Report 2004(WHO/HTM/TB). 2004; 331.
Global tuberculosis control 2009; epidemiology, strategy, financing, WHO Report 2009, Geneva, World health organization, 2009 (WHO/HTM/TB). 2009; 411
Toman K. Tuberculosis case finding and chemotherapy questions and answers. Geneva: WHO; 979.
Baganha MF, Pego A, Lima MA, Gaspar EV, Cordeiro AR. Serum and pleural adenosine deaminase. Correlation with lymphocytic populations. Chest. 1990; 97: 605.
Valdes L, Alvarez D, San Jose E, Juanatey JR, Pose A, Valle JM, et al. Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis Thorax. 1995 Jun; 50(6): 593-4
Naderi M, Hashemi M , Kouhpayeh H , Ahmadi R . The status of serum procalcitonin pulmonary tuberculosis and nontuberculosis pulmonary disease . J Pak Med Assoc 2005 ;9 :647_648
Rom. W.N. Garay S. Tuberculosis. First edition. 1996 Little- Brown and company.
Core curriculum on tuberculosis. 1996. CDC USA.
Anthony S, Fauci, at al, editors. Harrison’s Principles of internal medicine. 17th ed. United States. McGraw-Hill. 2008.
Review of tuberculosis epidemiology . Available from: www.wpro.who.int/NR/rdonlyres.
11) دکتر حسین حاتمی، کتاب جامع بهداشت عمومی، اپیدمیولوژی کنترل سل، فصل 9، گفتار 3
Jawetz, Melinick & Adelbergʼs medical microbiology, 25th. Ed, c2010
Hadian M. Causes a delay in diagnosis of TB. Journal of the Faculty of Medicine, Shahid Beheshti University 2000; 19(3): 70-77.
Baylan O , Balkan A , Inal A , Kisa O , Albay A , Doganci L. The predictive value of serum procalcitonin levels in adult patients with pulmonary tuberculosis. Jpn. J. Infect. Dis., 59, 2006, 164_167
Kang Y, Kwon S , Yoon H , Lee J , Lee C. Role of C-Reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.DOI:10.3904/Kjim.2009.24.4:337_342
SchleicherG.K , Herbert V , Brink A , Martin S , Maraj R , Feldman C , et all .procalcitonin and C- reactive protein levels in HIV- positive subjects with tuberculosis and pneumonia. Eur Respir J 2005 ; 25:688_689.
Polzin A , Pletz M , Erbes R , Raffenberg M , Mauch H , Wagner S , et all . procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.Eur respire J 2003 ;21:939_943
Kandemir O, Uluba B, Polat G, Sezer C, Camdeviren H, Kaya A. Elevation of procalcitonin level in patients with pulmonary tuberculosis and in medical staff with close patient contact. Arch Med Res 2003; 34: 311-4.
Munsiff SS, Alpert PL, Gourevitch MN, et al. A prospective Study of tuberculosis and HIV disease progression. J Acquir Immune Defic Synder 1998; 19: 361-66.
Mandell G, Bennett J, Dolin R. Principles and Practice of Infectious Diseases. 6th. Livingstone Churchill. 2005.
Mirsaeidi SM, Tabarsi P, Khoshnood K, Amiri M, Mansouri SD, Masjedi MR, Velayati AA. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International Journal of Infectious Disease. 2005 Nov; 9(6): 317-22.
Mirsaeidi SM, Tabarsi P, Edrisian O, Velayati AA. Tuberculosis resistant Multi drug Primary inf HIV out with patient lymphadenitis as presentedection. Monaldi Archives of Chest Disease; 2004; 61(4): 244-247.
Espinul MA, Laszlo A, Simonsen L, et al. Gbbal trends in resistance to anti tuberculosis drugs. N Engl J Med. 2001; 344(17): 1294-1303.
Mansoori SD, Agha Alaei SY, Arami S. Compractive study of initial and acquired drug resistance in pulmonary tuberculosis. Int Rev of the Armed Forces Med Services 2003; 79(1): 45-9.
AmaniF,Bashiri j, Sabzevari A, Garosi B, Nahan Moghadam N. Status of the epidemiology of tuberculosis in the city of Ardabil in 2001-2004. J Ardabil Univ Med Sci. 2006; 7(3):236-241. (Full Text in Persain)
Salek S, Masjedi M, salek S, Emami H ,Incidence survey of tuberculosis in different ethnic groups living in the Golestan province1999-2003, Iranian Journal of Epidemiology; VOLUME 3, NUMBER 3,4 ;2007: 15-20[Persian].
Shoraka H, Hosyni H, Alizadeh H, alavi nia M. Epidemiology of tuberculosis and associated factors in North Khorasan province during 2005-2010. Journal of North Khorasan University of Medical Sciences 2011. 3(3): 43-50.
Gholami a, Gharehaghaji R, Mousavi L, Sadaghiyanifar A. [Epidemiologic Survey of Pulmonary Tuberculosis in Urmia city during 2004-2007]. Knowledge Health. 2009;4(3): 19-23. [Article in Persian]
Mosavi GA, Saberi H, Sharif A, Ghorbani F, Shadkam M, Vojdani S, et al. [A comparative study of patients with pulmonary tuberculosis and extra pulmonary tuberculosis in Kashan]. Feyz. 2009;13(3): 235-41. [Article in Persian]
Hashemi A, Shojaei H, Heidarieh P, Aslani MM, Naser AD.Genetic diversity of Iranian clinical isolates of Mycobacterium tuberculosis. New Microbiol. 2012 Jan;35(1):61-5. Epub 2012 Jan 10.
Mohamadi Azni S, Mansourian A, Nokandeh Z. [Epidemiological study of tuberculosis in Damghan city (Iran) during 2003-2007]. Koomesh. 2008;9(4):315-20. [Article in Persian]
Rasmussen TA, Søgaard OS, Camara C, Andersen PL, Wejse C.Serum procalcitonin in pulmonary tuberculosis.Int J Tuberc Lung Dis. 2011 Feb;15(2):251-6
Afzali H, Taghavi N. Evaluation of clinical and laboratory adverse of TB patients. Feyz 2002; 5(4): 86-96[Article in Persian].
Ugajin M, Miwa S, Shirai M, Ohba H, Eifuku T, Nakamura H, Suda T, Hayakawa H, Chida K.Usefulness of serum procalcitonin levels in pulmonary tuberculosis.Eur Respir J. 2011 Feb;37(2):371-5.
.